Skip to main navigation
  • Overview
  • Press Releases
  • Events & Presentations
    • Upcoming Events
    • Past Events
    • Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Documents & Charters
  • Financial Information
    • SEC Filings
    • Swiss Statutory Financial Statements and Audit Reports
  • Stock Information
    • Stock Quote & Chart
    • Historical Price
    • Investment Calculator
  • Shareholder Services
    • Investor FAQs
    • Document Request
    • Contact IR
  • Back to CRISPR »

Press Releases

Press Releases

Keyword Search

May 16, 2022

CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer

May 12, 2022

CRISPR Therapeutics Announces Oral Presentation of New Clinical Data on Anti-CD70 Allogeneic CAR-T Therapy CTX130™ for Patients with T-cell Lymphoma at the Annual European Hematology Association (EHA) 2022 Hybrid Congress

May 09, 2022

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results

May 04, 2022

CRISPR Therapeutics to Present at the 2022 Bank of America Healthcare Conference

Apr 12, 2022

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Apr 07, 2022

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Mar 08, 2022

CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2022 Annual Meeting

Feb 28, 2022

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Feb 15, 2022

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Feb 09, 2022

CRISPR Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

Feb 02, 2022

CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)


Shareholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR

Interested in joining our team? Careers at CRISPR

© 2022 CRISPR Therapeutics. Contact | Privacy Policy | Terms and Conditions